J. Scott Wolchko - 22 Jul 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
President and CEO, Director
Signature
/s/ Cindy Tahl, Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
22 Jul 2021
Net transactions value
-$4,934,113
Form type
4
Filing time
26 Jul 2021, 16:05:21 UTC
Previous filing
24 May 2021
Next filing
20 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $81,900 +30,000 +7.6% $2.73 423,793 22 Jul 2021 Direct F1
transaction FATE Common Stock Sale $565,821 -6,627 -1.6% $85.38* 417,166 22 Jul 2021 Direct F1, F2
transaction FATE Common Stock Sale $1,876,711 -21,773 -5.2% $86.19* 395,393 22 Jul 2021 Direct F1, F3
transaction FATE Common Stock Sale $139,044 -1,600 -0.4% $86.90* 393,793 22 Jul 2021 Direct F1, F4
transaction FATE Common Stock Options Exercise $27,300 +10,000 +2.5% $2.73 403,793 23 Jul 2021 Direct F1
transaction FATE Common Stock Options Exercise $96,800 +20,000 +5% $4.84 423,793 23 Jul 2021 Direct F1
transaction FATE Common Stock Sale $2,558,538 -30,000 -7.1% $85.28* 393,793 23 Jul 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -30,000 -23% $0.000000 100,000 22 Jul 2021 Common Stock 30,000 $2.73 Direct F1, F5
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -10,000 -10% $0.000000 90,000 23 Jul 2021 Common Stock 10,000 $2.73 Direct F1, F5
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -20,000 -45% $0.000000 24,846 23 Jul 2021 Common Stock 20,000 $4.84 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.
F2 Represents the weighted average sale price of the shares sold ranging from $84.76 to $85.74 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F3 Represents the weighted average sale price of the shares sold ranging from $85.76 to $86.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F4 Represents the weighted average sale price of the shares sold ranging from $86.76 to $87.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
F5 This option is fully vested.